Selpercatinib benefit for advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer
Selpercatinib benefit for advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer
OncoAlert Round Up for September 8-14, 2023
Psilocybin-assisted psychotherapy for cancer-related anxiety and depression
Sudan: Conflict, cancer care, and ripple effects on the region
Geriatric oncology in resource-limited settings
Experiences of women caring for their husbands with cancer at the Cancer Diseases Hospital in Zambia
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine improves PFS in N2-3 nasopharyngeal carcinoma
2L triple metronomic chemo shows more efficacy in comparison to systemic therapy for head and neck cancer
ASCO 2023: Head and neck highlights
Tackling low-volumes of clinical trials in Africa
The HypoAfrica study and AC3T research partnerships at NLCC
Achieving health equity in cancer care in the Philippines